标题
Nilotinib – Differentiating the Hope from the Hype
作者
关键词
-
出版物
Journal of Parkinsons Disease
Volume 6, Issue 3, Pages 519-522
出版商
IOS Press
发表日期
2016-07-13
DOI
10.3233/jpd-160904
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration
- (2016) Saurav Brahmachari et al. JOURNAL OF CLINICAL INVESTIGATION
- Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
- (2016) Fernando Pagan et al. Journal of Parkinsons Disease
- Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma
- (2015) Sergio Manzano et al. EMERGENCY MEDICINE JOURNAL
- Are nilotinib-associated vascular adverse events an under-estimated problem?
- (2015) Marie Stève-Dumont et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
- (2014) Anne-Laure Mahul-Mellier et al. HUMAN MOLECULAR GENETICS
- Alterations of the biomarker S-100B and NSE in patients with acute vertebral spine fractures
- (2014) Harald Wolf et al. Spine Journal
- A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease
- (2014) Akie Tanabe et al. Frontiers in Cellular Neuroscience
- The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
- (2014) Senthilkumar S. Karuppagounder et al. Scientific Reports
- Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance
- (2013) Michaeline L. Hebron et al. Autophagy
- Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples
- (2013) Nicole V. Tolan et al. CLINICA CHIMICA ACTA
- Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
- (2013) M. L. Hebron et al. HUMAN MOLECULAR GENETICS
- Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
- (2013) Irina Lonskaya et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Parkin Plays a Role in Sporadic Parkinson's Disease
- (2013) Ted M. Dawson et al. Neurodegenerative Diseases
- Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model
- (2013) Syed Z. Imam et al. PLoS One
- c-Abl in Neurodegenerative Disease
- (2011) Sarah D. Schlatterer et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
- (2011) S. Z. Imam et al. JOURNAL OF NEUROSCIENCE
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
- (2010) H. S. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
- (2008) N. J. Diederich et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search